Prevalence and Molecular Characteristics of Drug-Resistant Mycobacterium tuberculosis in Hunan, China
Adult
Aged, 80 and over
DNA, Bacterial
Male
0301 basic medicine
China
Adolescent
Genotype
Antitubercular Agents
Microbial Sensitivity Tests
Mycobacterium tuberculosis
Sequence Analysis, DNA
Middle Aged
3. Good health
Young Adult
03 medical and health sciences
Drug Resistance, Bacterial
Mutation
Tuberculosis, Multidrug-Resistant
Humans
Female
Aged
Demography
DOI:
10.1128/aac.02426-14
Publication Date:
2014-04-15T03:30:53Z
AUTHORS (11)
ABSTRACT
ABSTRACT
To determine the prevalence and molecular characteristics of drug-resistant tuberculosis in Hunan province, drug susceptibility testing and spoligotyping methods were performed among 171
M. tuberculosis
isolates. In addition, the mutated characteristics of 12 loci, including
katG
,
inhA
,
rpoB
,
rpsL
, nucleotides 388 to 1084 of the
rrs
gene [
rrs
(388–1084)],
embB
,
pncA
,
tlyA
,
eis
, nucleotides 1158 to 1674 of the
rrs
gene [
rrs
(1158–1674)],
gyrA
, and
gyrB
, among drug-resistant isolates were also analyzed by DNA sequencing. Our results indicated that the prevalences of isoniazid (INH), rifampin (RIF), streptomycin (SM), ethambutol (EMB), pyrazinamide (PZA), capreomycin (CAP), kanamycin (KAN), amikacin (AKM), and ofloxacin (OFX) resistance in Hunan province were 35.7%, 26.9%, 20.5%, 9.9% 15.2%, 2.3%, 1.8%, 1.2%, and 10.5%, respectively. The previously treated patients presented significantly increased risks for developing drug resistance. The majority of
M. tuberculosis
isolates belonged to the Beijing family. Almost all the drug resistance results demonstrated no association with genotype. The most frequent mutations of drug-resistant isolates were
katG
codon 315 (
katG
315
),
inhA15
,
rpoB
531
,
rpoB
526
,
rpoB
516
,
rpsL
43
,
rrs
514
,
embB
306
,
pncA
96
,
rrs
1401
,
gyrA
94
, and
gyrA
90
. These results contribute to the knowledge of the prevalence of drug resistance in Hunan province and also expand the molecular characteristics of drug resistance in China.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (35)
CITATIONS (38)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....